Journal: Life
Article Title: Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
doi: 10.3390/life15010125
Figure Lengend Snippet: Detection of insulin immunoreactivity in insulin-deficient islets of children with recent onset T1D using different IF protocols. Left panel ( a , c , e ) demonstrates IF staining with increased concentrations of the primary antibodies (dilutions 1:50), increased incubation time (24 h) and AlexaFluor ® -conjugated secondary antibodies; positive staining for insulin in insulin-deficient islets is seen with rabbit polyclonal antibodies produced by Abcam (ab63820) ( e ), but not with mouse monoclonal antibodies produced by Thermo Fisher Scientific Inc. (MS-1379-P) ( a ) or rabbit polyclonal antibodies produced by Santa Cruz Biotechnology (Sc-9168) ( c ). Right panel ( b , d , f ) demonstrates IF staining with increased concentrations of the primary antibodies (dilutions 1:50), increased incubation time (24 h) and IFluor™-conjugated secondary antibodies; positive staining for insulin in insulin-deficient islets is seen with rabbit polyclonal antibodies produced by Abcam ( f ) and rabbit polyclonal antibodies produced by Santa Cruz Biotechnology ( d ), while the reaction with mouse monoclonal antibodies produced by Thermo Fisher Scientific Inc. still remains negative ( b ). Insulin-deficient islets are marked by dotted lines. Nuclei are stained by DAPI. Scale bar 50 µm.
Article Snippet: The relationships between insulin+ and glucagon+/insulin+ cells were analyzed on sections double-stained with mouse monoclonal antibodies to insulin (Sigma) and rabbit polyclonal antibodies to glucagon (Thermo Fisher Scientific Inc.).
Techniques: Staining, Incubation, Produced